{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:15:59Z","timestamp":1787026559125,"version":"build-2736575974"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The transition of care from paediatric to adult healthcare services is a vulnerable period for patients with inborn errors of immunity (IEI), a heterogeneous group of primary immunodeficiency disorders characterized by chronic immune dysfunction and significant morbidity. With advances in diagnosis and treatment, an increasing number of patients with IEI are now reaching adulthood, making the management of this transition a growing clinical priority. Inadequate transition is associated with medical complications, treatment non-adherence, discontinuity of care, increased healthcare utilization, and poorer long-term outcomes. Despite growing awareness, condition-specific and standardized transition guidelines for IEI remain largely absent, leaving clinicians without a clear framework to guide this critical phase. In this context, the present review proposes a structured, multidisciplinary transition protocol designed specifically for paediatric patients with IEI to support therapeutic adherence, continuity of care, and patient well-being. This practice-informed narrative review integrates a non-systematic appraisal of the available literature, expert clinical consensus, and the practical experience of a dedicated Italian centre. Central to this model are the early identification of patients eligible for transition, beginning around age 14, and the gradual involvement of a multidisciplinary team, with shared responsibility between paediatric and adult specialists throughout an overlap period of at least three years. Clear documentation, including a standardized clinical dossier and final transition report, along with measurable process and outcome indicators such as infection rates, follow-up adherence, and patient-reported quality of life, ensures continuity of care and ongoing support. The framework also addresses immunoglobulin replacement therapy options, including intravenous, subcutaneous, and facilitated subcutaneous immunoglobulin, which each offer distinct advantages depending on patient needs and life stage. Patient and caregiver empowerment, timely management of comorbidities, and regular reassessment of individual needs are core components. Although resource-intensive, the proposed model is designed to be adaptable to different healthcare settings. Limitations, including reliance on multidisciplinary resources and the absence of prospective validation, are acknowledged, and future research to evaluate its impact on clinical outcomes is warranted. Through coordinated, standardized strategies, this work aims to bridge the gap between paediatric and adult healthcare, reducing care discontinuity and supporting successful long-term disease management in adulthood.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1813944","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T04:23:54Z","timestamp":1778473434000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Inborn errors of immunity: a structured model for paediatric-to-adult transition of care"],"prefix":"10.3389","volume":"17","author":[{"given":"Adele","family":"Civino","sequence":"first","affiliation":[{"name":"Pediatric Rheumatology and Immunology Unit, \u2018Vito Fazzi\u2019 Hospital","place":["Lecce, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Diomeda","sequence":"additional","affiliation":[{"name":"Pediatric Rheumatology and Immunology Unit, \u2018Vito Fazzi\u2019 Hospital","place":["Lecce, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"D\u2019Orio","sequence":"additional","affiliation":[{"name":"Dietetics and Clinical Nutrition Unit, \u2018Vito Fazzi\u2019 Hospital","place":["Lecce, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Antonacci","sequence":"additional","affiliation":[{"name":"Pharmaceutical Department, ASL Bari","place":["Bari, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Loiacono","sequence":"additional","affiliation":[{"name":"Pediatric Rheumatology and Immunology Unit, \u2018Vito Fazzi\u2019 Hospital","place":["Lecce, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Vacca","sequence":"additional","affiliation":[{"name":"Unit of Internal Medicine \u201cGuido Baccelli\u201d, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari Aldo Moro, AUOC Policlinico Di Bari, University Hospital Policlinico Di Bari","place":["Bari, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baldassarre","family":"Martire","sequence":"additional","affiliation":[{"name":"Pediatrics and Neonatology Unit, Maternal-Infant Department, Monsignor A. R. Dimiccoli Hospital","place":["Barletta, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/J.JACI.2025.08.015","article-title":"A\u00a0scoping review of clinical management guidelines in inborn errors of immunity","author":"Murray","year":"2025","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.70962\/JHI.20250003","article-title":"Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"1","author":"Poli","year":"2025","journal-title":"J Hum Immun"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/J.JAIP.2019.02.004","article-title":"The european society for immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity","volume":"7","author":"Seidel","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/S10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"42","author":"Tangye","year":"2022","journal-title":"J\u00a0ClinImmunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/J.JACI.2024.01.011","article-title":"Validating inborn error of immunity prevalence and risk with nationally representative electronic health record data","volume":"153","author":"Rider","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/S10875-020-00844-0","article-title":"The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty years of experience (1999\u20132019)","volume":"40","author":"Lougaris","year":"2020","journal-title":"J ClinImmunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2023.1211524","article-title":"Transitioning from pediatric to adult healthcare with an inborn error of immunity: a qualitative study of the lived experience of youths and their families","volume":"14","author":"Ouimet","year":"2023","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/J.JACI.2020.08.010","article-title":"Consensus of the Italian Primary Immunodeficiency Network on transition management from pediatric to adult care in patients affected with childhood-onset inborn errors of immunity","volume":"146","author":"Cirillo","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2023.1263349","article-title":"Navigating the transition of care in patients with inborn errors of immunity: a single-center's descriptive experience","volume":"14","author":"Mej\u00eda Gonz\u00e1lez","year":"2023","journal-title":"Front Immunol"},{"key":"B10","unstructured":"Diagnostic, therapeutic, and care pathway for pediatric and adult patients with congenital immune disorders"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/1054-139X(93)90143-D","article-title":"Transition from child-centered to adult health-care systems for adolescents with chronic conditions: a position paper of the Society for Adolescent Medicine","volume":"14","author":"Blum","year":"1993","journal-title":"J\u00a0Adolesc Health"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/FPED.2022.956227","article-title":"Prevalence and barriers to health care transition for adolescent patients with childhood-onset chronic diseases across Japan: a nation-wide cross-sectional survey","volume":"10","author":"Sakurai","year":"2022","journal-title":"Front Pediatr"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/17482631.2023.2278904","article-title":"Transition from paediatric to adult health services: aspirations and practices of human flourishing","volume":"18","author":"Padley","year":"2023","journal-title":"Int J Qual Stud Health Well-Being"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/S10875-022-01345-Y","article-title":"Current transition practice for primary immunodeficiencies and autoinflammatory diseases in Europe: a RITA-ERN survey","volume":"43","author":"Israni","year":"2023","journal-title":"J ClinImmunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/S12016-021-08916-8","article-title":"Future of therapy for inborn errors of immunity","volume":"63","author":"Perez","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13223-024-00938-Z","article-title":"Inborn errors of immunity (primary immunodeficiencies)","volume":"20","author":"Kim","year":"2024","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B17","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-323-95061-9.00048-5","article-title":"Treatment of primary immunodeficiencies and inborn errors of immunity","volume-title":"Allergic and immunologic diseases: A practical guide to the evaluation, diagnosis and management of allergic and immunologic diseases","author":"Kobrynski","year":"2022"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2025.1532367","article-title":"Patient-centered outcomes with subcutaneous immunoglobulin use for infection control in primary and secondary immunodeficiencies: data of a GEIE Spanish Registry","volume":"16","author":"Mart\u00ednez Mercader","year":"2025","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2025.1640290","article-title":"Real-world patterns of immunoglobulin replacement therapy for infection prevention in common variable immunodeficiency: a multicenter nationwide study","volume":"16","author":"Moral Moral","year":"2025","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/S13223-022-00726-7","article-title":"A clinician's guide for administration of high-concentration and facilitated subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency diseases","volume":"18","author":"Epland","year":"2022","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/S13223-022-00746-3","article-title":"Immunoglobulin replacement therapy in patients with immunodeficiencies: impact of infusion method on patient-reported outcomes","volume":"18","author":"Mallick","year":"2022","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/S10875-024-01771-0","article-title":"Insights into patient experiences with facilitated subcutaneous immunoglobulin therapy in primary immune deficiency: a prospective observational cohort","volume":"44","author":"Yalcin Gungoren","year":"2024","journal-title":"J ClinImmunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/S10875-024-01838-Y","article-title":"Recommendations for transitioning young people with primary immunodeficiency disorders and autoinflammatory diseases to adult care","volume":"45","author":"Israni","year":"2024","journal-title":"J ClinImmunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2023.04.024","article-title":"Transition of care in inborn errors of immunity: outcomes of a single-center quality improvement initiative","volume":"11","author":"Sanchez","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/S12016-022-08950-0","article-title":"The treatment of primary immune deficiencies: lessons learned and future opportunities","volume":"65","author":"Paris","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2217\/IMT-2021-0167","article-title":"Facilitated subcutaneous immunoglobulin use in pediatric patients with primary or secondary immunodeficiency diseases","volume":"14","author":"Baumann","year":"2022","journal-title":"Immunotherapy"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1001\/JAMAPEDIATRICS.2015.0951","article-title":"Predictors of timing of transfer from pediatric- to adult-focused primary care","volume":"169","author":"Wisk","year":"2015","journal-title":"JAMA Pediatr"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2024.06.052","article-title":"Transitions of care in patients with inborn errors of immunity","volume":"12","author":"Prince","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1542\/PEDS.2021-055033","article-title":"Quality indicators for youth transitioning to adult care: a systematic review","volume":"150","author":"Bailey","year":"2022","journal-title":"Pediatrics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.jaip.2016.07.012","article-title":"Development and initial validation of a questionnaire to measure health-related quality of life of adults with common variable immune deficiency: the CVID_QoL questionnaire","volume":"4","author":"Quinti","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-200108000-00006","article-title":"PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations","volume":"39","author":"Varni","year":"2001","journal-title":"Med Care"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1813944\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T04:23:55Z","timestamp":1778473435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1813944\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":31,"alternative-id":["10.3389\/fimmu.2026.1813944"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1813944","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"article-number":"1813944"}}